What's in LENZ Therapeutics, Inc's pipeline?

LENZ Therapeutics, Inc has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with LENZ Therapeutics, Inc's portfolio?

Top competitors by shared drug class: Allergan, Maastricht University Medical Center, Ocuphire Pharma, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/lenz-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

LENZ Therapeutics, Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LENZ Therapeutics, Inc pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Aceclidine+Brimonidine combination ophthalmic solution	Aceclidine+Brimonidine combination ophthalmic solution	phase 3	Muscarinic agonist + alpha-2 adrenergic agonist combination	Muscarinic acetylcholine receptors; alpha-2 adrenergic receptors	Ophthalmology
Aceclidine ophthalmic solution	Aceclidine ophthalmic solution	phase 3	Muscarinic receptor agonist	Muscarinic acetylcholine receptors (M1, M3)	Ophthalmology

Therapeutic area mix

Ophthalmology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
Maastricht University Medical Center · 1 shared drug class
Ocuphire Pharma, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for LENZ Therapeutics, Inc:

Cite this brief

Drug Landscape (2026). LENZ Therapeutics, Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/lenz-therapeutics-inc. Accessed 2026-05-17.